CAH241220P115000
- 0.08
- -0.62-88.57%
Cardinal Health Newsroom
Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $136
Cardinal Health Analyst Ratings
Morgan Stanley Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $136
Cardinal Health Raised to Equal-Weight From Underweight by Wells Fargo
Cardinal Health Analyst Ratings
Wells Fargo Upgrades Cardinal Health(CAH.US) to Hold Rating, Raises Target Price to $127
Baird Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $149
Jefferies Maintains Cardinal Health(CAH.US) With Hold Rating, Raises Target Price to $125
J.P. Morgan Maintains Cardinal Health(CAH.US) With Hold Rating, Raises Target Price to $132
J.P. Morgan Remains a Hold on Cardinal Health (CAH)
JPMorgan Adjusts Price Target on Cardinal Health to $132 From $123, Maintains Neutral Rating
Wells Fargo Maintains Cardinal Health(CAH.US) With Sell Rating, Maintains Target Price $101
A Quick Look at Today's Ratings for Cardinal Health(CAH.US), With a Forecast Between $101 to $138
Evercore ISI Remains a Hold on Cardinal Health (CAH)
A Quick Look at Today's Ratings for Cardinal Health(CAH.US), With a Forecast Between $124 to $139
Cardinal Health Is Maintained at Overweight by Barclays
Cardinal Health Analyst Ratings
Cardinal Health's Strong Pharmaceutical Growth and Strategic Moves Justify Buy Rating
Barclays Maintains Cardinal Health(CAH.US) With Buy Rating, Maintains Target Price $133
TD Cowen Maintains Cardinal Health(CAH.US) With Hold Rating, Raises Target Price to $130